Previous 10 | Next 10 |
The #nextmove in a #stockprice is often identifiable in advance. This Biodelivery Sciences (NASDAQ: BDSI) report attempts to do that, and in the process help investors learn how price acton can be revealing. Trading plans for BDSI make these observations acti...
Image source: The Motley Fool. Biodelivery Sciences International Inc (NASDAQ: BDSI) Q1 2021 Earnings Call May 6, 2021 , 8:30 a.m. ET Operator Continue reading For further details see: Biodelivery Sciences International Inc (BDSI) Q1 2021...
The following slide deck was published by BioDelivery Sciences International, Inc. in conjunction with their 2021 Q1 earnings call. For further details see: BioDelivery Sciences International, Inc. 2021 Q1 - Results - Earnings Call Presentation
BioDelivery Sciences International, Inc. (BDSI) Q1 2021 Earnings Conference Call May 06, 2021, 08:30 ET Company Participants Mary Coelho - EVP, CFO & Treasurer Jeffrey Bailey - CEO & Director Scott Plesha - President & Chief Commercial Officer Conference Call Participants Brandon ...
BioDelivery Sciences International (BDSI) shares rise 2% during premarket trading after the company posted first-quarter revenue that increased 7%, driven by the sales of its BELBUCA treatment.This revenue growth was driven by BELBUCA net sales of $36.4M, which increased 9...
BioDelivery Sciences (BDSI): Q1 GAAP EPS of $0.05 misses by $0.01.Revenue of $41.02M (+7.2% Y/Y) misses by $0.05M.The Company reiterates its 2021 financial guidance, with full year 2021 total Company net sales of $170 - $180 million, including full year 2021 BELBUCA net sales of $15...
Total Company Net Revenue of $41 Million, an Increase of 7% versus Prior Year Net Income of $5.2 Million, EBITDA Margin of 22% and Operating Cash Generation of $11 Million Conference Call and Webcast Scheduled for 8:30 AM EST Today RALEIGH, N.C., May 06, 2021 (GLOBE ...
#Wallstreet usually prices in events before they happen, and that is as true for Biodelivery Sciences (NASDAQ: BDSI) as it is for any other company. If news is anticipated, and investors want to know what to expect, a simple review of the stock's price action is one of the best wa...
Some people say that timing does not matter, but it does. If you were to buy Biodelivery Sciences (NASDAQ: BDSI) at a high, see it fall, and not be able to buy more on the dip like the big boys can, that would be troubling. Over time, Stock Traders Daily has found a way to l...
RALEIGH, N.C., April 20, 2021 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious and complex chronic conditions, today announced that it will report its first quarter 2021 ...
News, Short Squeeze, Breakout and More Instantly...
BioDelivery Sciences International Inc. Company Name:
BDSI Stock Symbol:
NASDAQ Market:
BioDelivery Sciences International Inc. Website:
35 years industry experience including as CEO and founder of public company Stephen Squinto steps down as Chair for new role MILAN, Italy and NEW YORK, April 27, 2022 (GLOBE NEWSWIRE) -- Genenta Science (NASDAQ: GNTA), a clinical-stage biotechnology company pioneering the developm...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...